Artificial intelligence against the first wave of COVID-19: evidence from ChinaCOVID-19의 첫 번째 물결에 맞서는 인공 지능: 중국의 증거Article Published on 2022-06-102022-09-11 Journal: BMC health services research [Category] COVID19(2023년), SARS, 치료기술, [키워드] added artificial artificial intelligence Case fatality rate China confirmed cases contagious control variable control variables COVID-19 COVID-19 pandemic cumulative dependent variable dependent variables detect Diagnosis dimension disease Effectiveness evaluate Evidence Evolution Fatality rate feature First wave first-wave high risk Infection prevention interaction term Local mechanism OLS pandemic Poisson powerful tool prevention Prevention and control severe cases significant effect suggested the disease the epidemic Treatment variety widespread [DOI] 10.1186/s12913-022-08146-4 PMC 바로가기 [Article Type] Article
Clinical characteristics and outcomes of COVID-19 patients in Bali, IndonesiaObservational Study Published on 2022-06-102022-10-05 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 임상, [키워드] Accuracy Admission Anosmia ANOVA C-reactive protein cause Characteristics clinical clinical feature Clinical symptoms collected conducted coronavirus disease cough COVID-19 COVID-19 patient COVID-19 patients diagnostic diagnostic value diagnostics Dyspnea eight evaluate Factor fatigue febrile Fever high accuracy hospitals illnesses Indonesia intensive care interleukin-6 Laboratory Lymphocyte count marker Non-COVID-19 non-COVID-19 patient offered outcome Patient radiologic severe cases severe COVID-19 severity Symptoms symptoms of COVID-19 these symptom ventilator were assessed with COVID-19 [DOI] 10.1371/journal.pone.0269026 PMC 바로가기 [Article Type] Observational Study
Acute cardiac side effects after COVID-19 mRNA vaccination: a case seriesCOVID-19 mRNA 백신 접종 후 급성 심장 부작용: 사례 시리즈Case Reports Published on 2022-06-022022-09-11 Journal: European Journal of Medical Research [Category] COVID19(2023년), SARS, 변종, [키워드] affecting age analyzed approval Asymptomatic BNT162b2 cardiac adverse event cardiac adverse events Cardiac arrhythmia Case series case sery CDC criteria chest pain clinical Clinical data clinical information Containment COVID-19 defined determined by Diagnosis Dyspnea eight Electrocardiography elevated female females Germany healthy individuals Hospitalization Host Infection Inflammation Information System inoculation magnetic resonance imaging male males Mild Moderna MRI mRNA mRNA vaccination mRNA vaccine mrna-1237 mRNA-1273 myocarditis occur onset of symptoms organ damage pandemic pathophysiology Patient patients Pericarditis Registered reported required retrieved risk factor Risk factors SARS-CoV-2 second dose severe cases severity Side effect Support Symptom symptom onset the disease the vaccine troponin troponin levels vaccination Vaccine variants viral mutation was performed [DOI] 10.1186/s40001-022-00695-y PMC 바로가기 [Article Type] Case Reports
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study델타 변이체(B.1.617.2) 및 스코틀랜드 환자의 2차 접종 이후 경과 시간(REACT-SCOT)과 관련된 중증 COVID-19에 대한 백신 효능: 사례-대조군 연구Article Published on 2022-06-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] 95% CI age Alpha Analysis ascertainment bias B.1.1.7 B.1.617.2 booster doses Case-control case-control study ChAdOx1 ChAdOx1 vaccine classification coded community health Control controls COVID-19 Critical care database death declined decrease defined delta variant diagnosed dose Efficacy expected first positive Follow-up hospitalisation include index measure Moderna mRNA mRNA vaccine mRNA vaccines not limited outcome Patient Pfizer predominant presenting primary care primary outcome measure Protective replaced replacement report reported reversed risk SARS-CoV-2 variant Scottish second dose selected Severe case severe cases severe COVID-19 severe disease severity Sex study period suggested Support transmission rate transmission rates vaccination Vaccine vaccine efficacy Vaccines variant [DOI] 10.1016/S2213-2600(22)00045-5 PMC 바로가기 [Article Type] Article
Clinical characterization of COVID-19 breakthrough infections, PhilippinesCOVID-19 돌발 감염의 임상 특성, 필리핀Article Published on 2022-06-012022-09-11 Journal: Journal of Clinical Virology [Category] COVID19(2023년), SARS, 치료기술, [키워드] administration Alpha Asymptomatic Beta booster dose Breakthrough infection breakthrough infections characterized clinical clinically CoronaVac COVID-19 Ct values Delta VOC Evidence HCW HCWs healthcare worker Healthcare workers Inactivated vaccine majority male PCR Philippines risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 transmission sequenced severe cases significantly lower symptomatic viral loads VOCs [DOI] 10.1016/j.jcv.2022.105157 PMC 바로가기 [Article Type] Article
Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice치명적인 K18-hACE2 마우스에서 SARS-CoV-2 Delta 변이체에 대한 ZF2001의 효과적인 보호Article Published on 2022-05-202022-09-11 Journal: Virology Journal [Category] COVID19(2023년), SARS, 변종, [키워드] aluminum approval China Delta delta variant Efficacy Epidemics hACE2 improvement K18-hACE2 K18-hACE2 mice K18-hACE2 transgenic mice Lung histopathology mechanism neutralizing antibody omicron Prevent protection Protective protective effect protein subunit vaccine reduced required Research research and development SARS-CoV-2 SARS-CoV-2 Delta variant severe cases severe pneumonia Subunit vaccine survival rates the SARS-CoV-2 Vaccine Vaccine design variant virus was used ZF2001 ZF2001. [DOI] 10.1186/s12985-022-01818-x PMC 바로가기 [Article Type] Article
Comparative Analysis of Age, Sex, and Viral Load in Outpatients during the Four Waves of SARS-CoV-2 in A Mexican Medium-Sized City멕시코 중소 도시에서 SARS-CoV-2의 4가지 물결 동안 외래 환자의 연령, 성별 및 바이러스 부하 비교 분석Article Published on 2022-05-082022-09-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 변종, [키워드] age age groups analyzed appearance both sexes can be used city collected Comparative Contagion COVID-19 current Decision-making effective Follow-up Frequency Health load measure men Outpatient outpatients Patient positive patient positive patients Prevalence public health qRT-PCR SARS-CoV-2 severe cases Sex significantly higher Spread Symptomatic treatment Treatment undergo variant Viral load Wave Waves women [DOI] 10.3390/ijerph19095719 PMC 바로가기 [Article Type] Article
Comparison of chest CT severity scoring systems for COVID-19COVID-19에 대한 흉부 CT 중증도 점수 시스템 비교Article Published on 2022-05-012022-09-11 Journal: European Radiology [Category] COVID19(2023년), SARS, 치료기술, [키워드] abnormality Accuracy asked AUC calculated Chest CT Clinical severity Computed tomography Computed tomography, X-ray coronavirus COVID-19 CT chest cutoff value demonstrated diagnostic Diagnostic accuracy discrimination female FIVE highest Interpretation lung lung involvement male observation Patient PCR-confirmed PCR-confirmed COVID-19 pulmonary involvement Quantitative reported Reporting Retrospective study ROC Curve ROC curves SARS-CoV-2 scoring system Severe case severe cases severity significantly specificity statistically significant time tomography TSS X-ray [DOI] 10.1007/s00330-021-08432-5 PMC 바로가기 [Article Type] Article
Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19COVID-19 진단 및 예후를 위한 실험실 바이오마커Review Published on 2022-04-272022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, [키워드] Admission Analysis aspartate Aspartate transaminase AST Biomarker Biomarkers BNP Brain brain natriuretic peptide cause clinical manifestations Clinical practice coronavirus disease Coronavirus disease 2019 COVID-19 creatine creatine kinase Cytokines D-dimer Diagnosis diagnostic disease severity focus Future Hospitalization ICU identify include Inflammation intensive care intensive care unit laboratory biomarker laboratory biomarkers Lactate lactate dehydrogenase LDH Lymphocytes metabolomic metabolomics Mortality multiorgan failure Myoglobin N-terminal Neuron-specific enolase neutrophil neutrophil count Neutrophils NT-proBNP outcome outcomes peptide predict Prognosis Prognostic value progression proinflammatory cytokines proteomic proteomics Research respiratory risk stratification SARS-CoV-2 Severe acute respiratory syndrome severe cases severe COVID-19 shown translated [DOI] 10.3389/fimmu.2022.857573 PMC 바로가기 [Article Type] Review
Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling수학적 모델링을 통한 COVID-19 심각도 및 후유증의 면역학적 및 임상적 예측인자 식별Article Published on 2022-04-202022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] absolute neutrophil count Analysis Aritficial Intelligence biochemical biochemical markers Biochemical parameters Blood urea nitrogen C-reactive protein clinical Cohort control subject control subjects coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients COVID-19 severity Critical curated cytokine Cytokines dataset differential expression disease severities Efficacy exploratory ferritin granzyme B highlight identify identifying IFN-γ IL-1 IL-10 IL-15 IL-1ra IL-6 immunological Increased Initially interferon Interferon-gamma interleukin investigated Lactate lactate dehydrogenase Liver injury machine machine learning methodology modeling multiplex Multiplex assay Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples Necrosis neutrophil nitrogen outcome pandemic pathophysiology pathway Patient PD-L1 potential therapeutic targets predict Predictive predictive models Predictive value predictor radiological receptor RNA RNA seq ROC ROC analysis serum severe cases severity the disease transcriptomics tumor necrosis urea validation cohort variant [DOI] 10.3389/fimmu.2022.865845 PMC 바로가기 [Article Type] Article